• OVPR

    The Office of the Vice President for Research facilitates collaborative research opportunities, streamlines related policies and procedures, and acts as a unified voice for U of I research.

  • UIC OTM

    The Office of Technology Management at Chicago is responsible for managing the intellectual property generated by research and educational activities at the University.

  • UIC Research Center

    Supplies a fully-equipped infrastructure and access to University resources, internship programs, world-class talent, and custom-designed business development services.

  • UI Research Park

    Provides an ideal environment for starting a high-growth technology venture, with wet-chemistry labs, office space, an array of shared equipment, server co-location facilities, and conference rooms.

  • IllinoisVENTURES

    IllinoisVENTURES is a seed and early-stage technology investment firm focused on research-derived companies in information technologies, physical sciences and life sciences, with a particular emphasis on those deriving from research conducted at the University of Illinois and other regional research institutions and federal laboratories.

Office of Technology Management, Urbana-Champaign

Follow OTM on Social Media!

Recap of Supporting Innovation & Creativity: A Conversation with the Arts, Humanities & Social Sciences

Supreme Court Rules On Patentability of Genes

Summer 2013 Technology Highlights To Date
Syndicate content

Featured Start-Up

Cornboard Manufacturing Inc

Featured Technology

Treatment Method for Salt-Sensitive Hypertension
Syndicate content
Syndicate content

Inventor's Handbook

A Handbook for Inventors and Innovators: Technology Transfer at the University of Illinois

An introduction to the University’s intellectual property policies, patenting and commercialization services, intellectual property fundamentals, and most importantly, to your role in the process of commercializing University innovations. Learn more.

Latest Technologies

Microfluidic Device Platform for Perfusion Chamber Systems
In stroke research, the hippocampal acute brain slice preparation is a model for studying how neuronal tissue responds to a hypoxic insult. Additionally, in diabetes research, pancreatic islets preparation and dynamic loading of oxygen and glucose is critical to understand how hypoxia alters the glucose-insulin response of the pancreas. However, standard techniques using commercial perfusion chambers cannot accurately provide oxygen delivery and control to model hypoxic conditions.
Nexturastat, a novel Urea-based HDAC6 inhibitor effective against specific cancers
Histone deacetylases (HDACs) mediate regulation of gene expression via changes in nucleosome conformation.  Dysregulation of histone acetylation, can lead to the development of cancers. There is renewed interest in capitalizing new breakthroughs in epigenetic research to address oncology therapy. Epigenetic regulation and subsequent gene expression or silencing represents a tightly orchestrated interplay among enzymes responsible for modifying the tails of histones, around which nuclear DNA is wrapped.
Novel Isoxazole-Based HDAC6 Selective Inhibitors for the Treatment of Charcott-Marie-Tooth (CMT), a new epigenetic approach to therapy
Histone deacetylases (HDACs) mediate regulation of gene expression via changes in nucleosome conformation.  Dysregulation of histone acetylation, involving CBP, a neuroprotective transcription factor with histone acetyltransferase activity, has been found in Huntington’s disease (HD), Alzheimer’s disease (AD), and Rubinstein-Taybi syndrome. In a cellular model of AD, cell death was accompanied by loss of CBP function and histone deacetylation. 
Carbazole Derivatives as G9a Methyltransferase Inhibitors for Cancer Treatment and Autophagy Induction.
G9a is overexpressed in various human cancer including leukemia, prostate cancer, hepatocellular carcinoma and lung cancer. Inhibitors of G9a are candidates for cancer treatment. A new family of G9A inhibitors have been recently identified and characterized. Through the characterization of these inhibitors, insight has been gained on the mechanistic contribution of G9a in the deregulation of the cell cycle in cancer and methyltransferase G9a regulation of a crucial step in cellular degradation.
Syndicate content

Search Technologies

Search Start-ups

Featured Start-ups

CASI, Computational Applications and System Integration, Inc.

http://www.casicorp.com/

Development and licensing of mission-critical solvers for solutions of linear systems.

Last updated on Jul 26, 2010 (Created on Jun 05, 2010)

Common Ground Publishing

http://www.commongroundpublishing.com/

Common Ground is a producer and manager of content for print and the internet. The company works in four areas: conferences, publishing, research, and software.

Last updated on Jul 26, 2010 (Created on Jun 05, 2010)

Numentek America, Inc.

http://www.numentek.com/

Numentek America Incorporation is a high technology venture company established by Numentek Co., Ltd in South Korea for manufacturing state-of-the-art lasers and optical instruments targeting biomedical and bioengineering applicaitons .

Last updated on Jul 26, 2010 (Created on Jun 05, 2010)
print